Clinical trial
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis…
NCT00001266 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001266 |
|---|---|
| Title | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma |
| Official title | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasm |
| Intervention type | Drug |
| Interventions | Suramin |
| Enrollment | 70 |
| Start date | Oct 1, 1990 |
| Completion | Aug 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: